Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study
Author:
Affiliation:
1. Bristol-Myers Squibb; Princeton NJ USA
Funder
Bristol-Myers Squibb
Pfizer
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13815/fullpdf
Reference46 articles.
1. Bristol-Myers Squibb Coumadin prescribing information http://packageinserts.bms.com/pi/pi_coumadin.pdf
2. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial;Goldstein;Lancet,2015
3. Boehringer Ingelheim Pradaxa (dabigatran) PI http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206316lbl.pdf
4. Idarucizumab for dabigatran reversal;Pollack;N Engl J Med,2015
5. Reversing the effect of oral anticoagulant drugs: established and newer options;Ansell;Am J Cardiovasc Drugs,2016
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Beware the counsel of the oracle;Journal of the American College of Emergency Physicians Open;2023-10
2. Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice;European Journal of Cardio-Thoracic Surgery;2023-10-01
3. Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants;Annals of Emergency Medicine;2023-09
4. Management of major bleeding for anticoagulated patients in the Emergency Department: an European experts consensus statement;European Journal of Emergency Medicine;2023-07-07
5. Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale;TH Open;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3